Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
bone marrow diseases
MeSH D001855 - bone marrow diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006402:
Hematologic diseases
33 Companies
3 Drugs
$
Success rate
D001855:
Bone marrow diseases
17 Companies
1 Drug
$
Success rate
D000080983:
Bone marrow failure disorders
0 Companies
0 Drugs
Success rate
D009190:
Myelodysplastic syndromes
32 Companies
6 Drugs
$
Success rate
D009196:
Myeloproliferative disorders
2 Companies
2 Drugs
$
Success rate
D019046:
Bone marrow neoplasms
0 Companies
0 Drugs
Success rate
D054437:
Myelodysplastic-myeloproliferative diseases
19 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
33
%
3/9
Phase 2
0
%
0/6
Phase 3
14
%
1/7
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Carboplatin
Mylan
Carboplatin
Sandoz
Carboplatin
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use